Rather, the treatment induced a moderate reduction in NEC incidence, accompanied by increased intestinal villus heights and peptidase activities that are good markers of villus integrity and function in preterm pigs (25–29). This evidence concerns the gene LAP3 and necrotizing enterocolitis.